Abstract
Hydroxychloroquine (HCQ) is a drug being increasingly used in the treatment of various autoimmune disorders. Retinal toxicity is a complication of prolonged use causing permanent visual loss in patients receiving HCQ. We report a case of HCQ retinopathy who received the drug for 35 years for rheumatoid arthritis. She had never been advised for ophthalmologic evaluation before. Interprofessional collaboration will help in the early detection of retinal damage, treatment with alternate drugs, and prevention of permanent retinal damage.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
